The MarketWatch News Department was not involved in the creation of this content. -- Marks HeartBeam's transition to commercial company -- Rapidly growing practice and highly engaged member population ...

Boston, MA, September 3, 2025: ECG Management Consultants, a leading healthcare consulting firm to health systems, physicians, and investors, today announced the launch of Cipher Collective, a curated ...

Southlake, TX, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. (HSCS) d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, Inc., a leading AI-driven health technology company and portfolio company of nference, announced today it has received the 2024 MedTech Breakthrough Award ...

HeartBeam (NASDAQ: BEAT), a medical technology company developing personalized cardiac-care insights, detailed its strategy following receipt of a Not Substantially Equivalent decision for its 510 (k) ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, a leading artificial intelligence (AI)-driven health technology company, announced that the Centers for Medicare & Medicaid Services (CMS) has included its ...

HeartSciences Inc., an AI-powered medical technology company focused on transforming ECGs for earlier heart disease detection, provided a financial update for the third quarter of fiscal 2025, ...

Sudden cardiac events (SCEs) are the leading cause of line-of-duty deaths (LODDs) among firefighters in the United States, so it is obvious why there is such an appeal for electrocardiogram (ECG) ...

HeartSciences Inc., a medical technology company based in Southlake, TX, has received a new patent from the USPTO for its AI-powered ECG technology, which enhances the estimation of echocardiography ...

HeartBeam BEAT recently secured FDA 510(k) clearance for its first-of-its-kind, cable-free synthesized 12-lead ECG technology, marking a major inflection point in the company’s mission to modernize ...

FDA-cleared technology makes clinical-grade ECG insights for arrhythmia assessment available outside of a medical facility SANTA CLARA, Calif.--(BUSINESS WIRE)-- HeartBeam, Inc. (BEAT) (NASDAQ: BEAT), ...

HeartBeam (NASDAQ: BEAT) was among the medical device companies highlighted in a Jan. 8 report by Modern Healthcare by Lauren Dubinsky that outlined FDA clearances and approvals across the medical ...